New implants linked to less infection and better recovery from orthopedic surgery
Superior knee and hip replacements are a step closer after Flinders University and Chinese researchers further test and develop a new orthopedic implant coating which has the strong ability to ward off infection-as well as stimulate bone growth.
The technology, which has been patented after more promising results just detailed in the lead scientific journal Advanced Functional Materials, consists of novel Silver-Gallium (Ag-Ga) nano-amalgamated particles that can be easily applied to medical device surfaces.
“The antibacterial capabilities of compounds derived from silver have been extensively researched. However, the cytotoxicity of silver ions currently poses a significant obstacle for the utilisation of silver ions in medical materials,” says corresponding author Dr Vi-Khanh Truong, from the Biomedical Nanoengineering Laboratory (BNL) at Flinders University.
“Our new formula involving Ag-Ga nano-amalgamation ensures the sustained release of silver and gallium ions in a very controlled manner to eliminate these issues.”
Senior author Matthew Flinders Professor Krasimir Vasilev, director of the Biomedical Nanoengineering Laboratory at the College of Medicine and Public Health at Flinders University, says the discovery provides an urgently needed solution to medical device-associated infections.
“The new material could be easily and controllably applied by spray-casting on many medical devices to protect them against infection, and also provide anti-inflammatory effect and stimulate bone growth,” says Profesor Vasilev.
“Our latest testing indicates this combination of antibacterial protection and tissue integration properties can benefit many devices in the orthopedic, trauma, and also dental areas.”
Infections after orthopedic implant surgery are a global health issue, with rates ranging from 2% to 10% in developed countries and up to 15% in developing regions.
In the US alone, there are more than 100,000 cases of orthopedic device-related infections. A 2017 Australian study showed a 1.7% infection rate post-hip or knee replacements. About 6% of orthopedic implant infections lead to intensive care with a mortality rate up to 4.6%. The cost of treating such infections can exceed US$100,000 per case.
The latest testing was supported by collaborator including Professor Yunpeng Zhao, a surgeon at the Qilu Hospital and University of Shandong colleagues in China.
The Ag-Ga nano-amalgamated particles exhibited potent antimicrobial properties against a broad spectrum of bacterial strains in animal models.
Dr Truong, from the Flinders Biomedical Nano-engineering Laboratory, says the discovery has the potential to apply to various implantable devices, catheters and other access devices, and even wound dressings where infections are also problematic.
“Commercialisation opportunities could make this solution available to clinicians and patients in the near future – at a time when growing antibiotic resistance is yet another problem in global healthcare.”
GaLM was used to facilitate the galvanic deposition of silver nanocrystals (Ag) on oxide layer. The GaLM not only serves as a carrier for silver through the galvanic replacement process but also provides a controlled-release mechanism for silver.
Reference:
Tien Thanh Nguyen, Pengfei Zhang, Jingwei Bi, Ngoc Huu Nguyen, Yen Dang, Zhaoning Xu, Hao Wang, Neethu Ninan, Richard Bright, Tuyet Pham, Chung Kim Nguyen, Ylias Sabri, Manh Tuong Nguyen, Jitraporn Vongsvivut, Yunpeng Zhao, Krasimir Vasilev, Vi Khanh Truong, Silver─Gallium Nano-Amalgamated Particles as a Novel, Biocompatible Solution for Antibacterial Coatings, https://doi.org/10.1002/adfm.202310539.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.